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Investigation of the mechanism of tau polymerization is indispensable for ﬁnding inhibitory condi-
tions or identifying compounds preventing the formation of paired helical ﬁlament or oligomers.
Tau contains a microtubule-binding domain consisting of three or four repeats in its C-terminal
half. It has been considered that the key event in tau polymerization is the formation of a b-sheet
structure arising from a short hexapeptide 306VQIVYK311 in the third repeat of tau. In this paper,
we report for the ﬁrst time that the C–H  p interaction between Ile308 and Tyr310 is the elemental
structural scaffold essential for forming a dry ‘‘steric zipper” structure in tau amyloid ﬁbrils.
 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction tau polymerization is the formation of a b-sheet structure arisingTau is normally found in axonal microtubules (MTs) and plays a
role in the regulation of MT formation and stabilization [1]. This
MT-associated tau is a highly soluble protein and shows hardly
any tendency to assemble under physiological conditions. In the
brains of Alzheimer’s disease (AD) patients, however, tau dissoci-
ates from axonal MTs through an extensive phosphorylation and
aggregates intracellularly to form an insoluble paired helical ﬁla-
ment (PHF) called the neuroﬁbrillary tangle [2]. Investigation of
the mechanism of tau polymerization is hence indispensable for
ﬁnding inhibitory conditions or identifying compounds preventing
the formation of PHFs or oligomers, which may slow down or even
reverse neuronal disease in AD. Tau contains a microtubule-bind-
ing domain (MBD) consisting of three or four repeats in the C-ter-
minal half (Fig. 1), and it has been considered that the key event inchemical Societies. Published by E
BD, four-repeated MBD; AD,
tidine; EM, electron micros-
ubule; PCR, polymerase chain
odium dodecyl sulfate poly-
ThS, thioﬂavin S
oura), tomoo@gly.oups.ac.jpfrom the short hexapeptide 306VQIVYK311 in the third repeat of
tau [3,4]. X-ray crystal analysis [5] showed that this sequence
adopts a b-strand conformation and forms parallel b-sheets with
other VQIVYK sequences that combine in a face-to-face interdigi-
tating dry ‘‘steric zipper” structure and form amyloid-like ﬁbrils
with the same cross b-structure found in full tau amyloid ﬁbrils.
To investigate the function of the Tyr310 residue in MBD ﬁlament
formation, we have, recently, investigated the aggregation behav-
ior of a series of Tyr-substituted, deleted or inserted MBD mutants
and clariﬁed the importance of Tyr located speciﬁcally at position
310 [6]. In this communication, we report for the ﬁrst time that
the ﬁlament formation of MBD is accomplished by the interplay
between Ile308 and Tyr310, not by Tyr310 alone. This new result
indicates the initial structural scaffold essential for forming a dry
‘‘steric zipper” structure in tau amyloid ﬁbrils.2. Materials and methods
2.1. Chemicals
Heparin (average molecular weight = 6000) and thioﬂavin S
(ThS) were purchased from Sigma Co. The other commercially
available materials used were of reagent grade or higher.lsevier B.V. All rights reserved.
Fig. 1. Schematic of entire four-repeat human tau (A) and amino acid sequences of the third repeat peptide of MBD (B). The number of tau amino acid residues refers to the
longest isoform of human tau (441 residues).
Table 1
Changes in ThS ﬂuorescence, CD and EM morphology of 4RMBD mutants and wild-
type 4RMDÅ@or tau (25 mM) at 25 h after starting aggrega.
Mutant Relative
ﬂuorescence
intensity (%)
Relative change
(%) of molar
ellipticity at
200 nm
EM picture
Wild 4RMBD 100 100 Filament
V306Y/Y310A 0 10 Granule (+1)
Q307Y/Y310A 100 90 Filament
I308Y/Y310A 0 0 No granule and no
ﬁlament
V309Y/Y310A 20 10 Granule (+2)
Y310A/K311Y 5 5 Granule (+1)
V306A/Y310 80 80 Filament
Q307A/Y310 50 30 Short ﬁlament
I308A/Y310 0 0 No granule and no
ﬁlament
V309A/Y310 50 30 Short ﬁlament
K311A/Y310 90 100 Filament
Q307Y/V309A/
Y310A
0 0 No granule and no
ﬁlament
Wild-type tau 100 100 Filament
Y310A 0 0 No granule and no
ﬁlament
I308A/Y310 0 0 No granule and no
ﬁlament
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substituted mutants
The gene expression and puriﬁcation of histidine (His)-tagged
three-repeated MBD (3RMBD) and 4RMBD of human brain tau
were performed using methods described in a previous paper [6],
and the purities of these domains were conﬁrmed by sodium dode-
cyl sulfate polyacrylamide gel electrophoresis (SDS–PAGE).
The Tyr or Ala-substituted genes of 4RMBD were constructed
from human 2N4R by the thymine adenine cloning. After ampliﬁca-
tion by the polymerase chain reaction using a primer designed for
producing each intended gene and rTaq polymerase, each gene was
veriﬁed by forward and reverse dideoxy sequencings and inserted
into the pET-23 vector treated with NdeI–SalI restriction enzymes
and transformed into the BL21(DE3) strain. The puriﬁcation of
His-tagged MBD mutant was performed using a combination of
cation exchange chromatography (HiPrep™ 16/10 SP-FF) [gradient
method of sample solution (50 mM Tris–HCl buffer, pH 7.6) by 0–
1 M NaCl] and Ni-chelating afﬁnity chromatography (Chelating
Sepharose™ Fast Flow) [binding: 50 mM Tris–HCl buffer (pH
7.6) + 0.5 M NaCl + 10 mM imidazole; elution: 50 mM Tris–HCl
buffer (pH 7.6) + 0.5 M NaCl + 100 mM imidazole]. The purity of
each peptide was conﬁrmed by SDS–PAGE. The concentration of
each sample was determined by measuring UV absorption at
280 nm (e = 1280 mol1 L cm1 for Tyr residue) and Bradford pro-
tein assay.
2.3. ThS ﬂuorescence measurement
The 25 lM solution of each sample was prepared using 50 mM
Tris–HCl buffer (pH 7.6), and 10 lM ThS was added to each solu-
tion. Fluorescence intensity was measured using a JASCO FP-6500
instrument with a 2 mm quartz cell maintained at 25 C using a
circulating water bath. After adding 6.25 lM heparin (optimal con-
centration for aggregation) to each sample solution, the aggrega-
tion proﬁle of each sample was monitored by plotting the time
course of ﬂuorescence intensity with excitation at 440 nm and
emission at 500 nm. The background ﬂuorescence of each sample
solution was subtracted when necessary. The same measurement
was repeated at least three times using newly prepared samples
to conﬁrm the reproducibility, and the averaged values were used
for the data presentation.
2.4. Circular dichroism (CD) measurement
The 25 lM solution of each sample was prepared using 20 mM
phosphate buffer (pH 7.6). After adding 6.25 lM heparin to each
sample solution, the CD spectral change was monitored as a func-
tion of the time course of the reaction. All measurements were ta-
ken at 25 C with a JASCO J-820 spectrometer in a cuvette with a
0.5 mm path length. For each experiment under N2 gas ﬂow, the
measurement from 190 to 250 nm was repeated eight times and
the results were summed. The same measurement was repeatedat least three times using newly prepared samples to conﬁrm the
reproducibility of the results. Data are expressed in terms of mean
residual ellipticity [h] in deg cm2 dmol1.
2.5. Electron microscopy (EM) measurement
The 25 lM solution of each sample was mixed with 6.25 lM
heparin in 50 mM Tris–HCl buffer (pH 7.6) and then incubated at
37 C for 48 h. Copper grids (600 mesh) were used for negative-
staining EM. One drop of each protein solution and one drop of
2% uranyl acetate were placed on the grid. After 1 min, excess ﬂuid
was removed from the grids. Negative-staining EM was performed
using an electron microscope (Hitachi Co.) operated at 75 kV.
3. Results and discussion
3.1. Aggregation behavior of four-repeated MBD (4RMBD) mutant
The aggregation behavior of a series of 4RMBD mutants, in
which each residue in the 306VQIVYK311 sequence was substituted
with Ala or Tyr, was investigated by ThS ﬂuorescence measure-
ment, CD spectroscopy, and EM. The results are summarized in Ta-
ble 1 and representative results are shown in Fig. 2. A considerable
aggregation ability of 4RMBD was lost with Y310A mutation de-
spite the substitution of Tyr for other residues in the 306VQIVYK311
sequence, except for Q307Y/ Y310A. Among them, the complete
loss was observed for the I308Y/Y310A mutant. Note that the loss
Fig. 2. Time-dependent ThS ﬂuorescence intensity proﬁles (A), time-dependent CD spectra (B–D), and negative-staining EM images of wild 4RMBD and its I308A and Q307Y/
Y310A mutants (E–G). The Q307Y/V309A/Y310A mutant shows essentially the same ﬁgures as I308A. The respective CD spectra correspond to 0 min, 3, 6, and 24 h after
adding heparin to the solution (horizontal axis from bottom to top at 200 nm). The length of the bar in (E–G) corresponds to 500 nm.
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3RMBD and full-length tau, indicating that the Tyr310 in the third
repeat of MBD is essential for the ﬁlament formation of tau, as re-
ported in related studies [6–8].
In contrast, it is remarkable that the Q307Y/Y310A mutant still
shows a similar aggregation proﬁle and ﬁlament morphology to
wild-type 4RMBD. This ﬁrst-time observation indicates that the
aggregation pathway of the Q307Y/Y310A mutant is the same
as that of wild-type 4RMBD. To determine why the Q307Y/
Y310A mutant exhibits such potent aggregation, the aggregation
behavior of the Y310-ﬁxed and Ala-scanned mutants for each res-
idue in the 306VQIVYK311 sequence in 4RMBD was investigated;
the results are given in Table 1. As a result, it was observed for
the ﬁrst time that the I308A mutant lost its aggregation ability
completely, whereas the other mutants still showed aggregation
ability, although their ability was reduced to a certain extent.
The complete loss of the aggregation ability of the I308A mutant
indicates that the close interaction between I308 and Y310 is
essential for 4RMBD self-aggregation. The crystal structure [5]
of VQIVYK showed a close contact between the side chain ofI308 and the aromatic ring of Y310. This and the present results
suggest the importance of an intramolecular C–H  p interaction
between both side chains for ﬁlament formation. Although a sim-
ilar C–H  p interaction is possible between Val306 and Tyr308 in
the I308Y/Y310A mutant, the lack of notable ﬁlament formation
indicates that the existence of a C–H group on the N-terminal
side with respect to Tyr310 is important for ﬁlament formation
via a C–H  p interaction.
3.2. Importance of C–H  p interaction between I308 and Y310
residues for ﬁlament formation of 4RMBD
On the other hand, similar C–H  p interaction to that in wild-
type 4RMBD could be expected between the side chains of Y307
and V309 in the potent aggregative Q307Y/Y310A mutant.
Although the direction of their side chains is opposite to those of
I308 and Y310 with respect to the b-strand 306VQIVYK311 plane,
the mutual spatial disposition between the V309 side chain and
Y307 aromatic ring is the same as that between the side chains
of I308 and Y310.
Fig. 3. Probable molecular packing of VQIVYK (305–310) peptide with NNQQNY-like array [11]. The dotted lines represent hydrogen bonds.
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formation, no aggregation ability of the Q307Y/V309A/Y310A mu-
tant should be expected. To conﬁrm this possibility, the aggrega-
tion proﬁle of the mutant was investigated and a complete loss
of aggregation was observed, supporting again the importance of
the C–H  p interaction between I308 and Y310 for the ﬁlament
formation of 4RMBD. In fact, the importance of this C–H  p inter-
action was conﬁrmed for full-length tau.
3.3. General discussion on the role of C–H  p interaction in tau
ﬁlament formation
The C–H  p interaction is a kind of hydrogen bond occurring
between the C–H donor and the aromatic p acceptor, and contrib-
utes signiﬁcantly to the stability of the three-dimensional struc-
ture of a protein [9,10]. Thus, it would be reasonable to consider
that this C–H  p interaction serves as a ‘‘conformational seed”
for forming self-aggregation of tau protein. The crystal structure
of the tau segment peptide VQIVYK has been used to discuss a
model of ﬁbrils of MBD and full-length tau, because it provides a
molecular view of the structural organization of the spine of tau ﬁ-
brils [5]. In the crystal structure, the sequence adopts a b-strand
conformation and forms parallel b-sheets with other VQIVYK se-
quences that combine in a face-to-face interdigitating dry ‘‘steric
zipper” structure, where the back surfaces between the sheets con-
stitute wet interfaces linked by water molecules. Because no inter-
molecular close contact between the Y and I residues is formed in
the molecular packing of this segment, the intramolecular close
contact via C–H  p interaction is essential for the stabilization of
b-strand conformation, which is necessary for the parallel b-sheet
formation of the dry ‘‘steric zipper” structure.
Interestingly, the molecular packing of the cross b-spine of the
GNNQQNY peptide segment from Sup35 [11] appears to be more
suitable for interpreting the present aggregation behavior of the
tau mutant. Although this fragment forms parallel b-sheets of the
face-to-face interdigitating dry ‘‘steric zipper” structure similar to
those of VQIVYK sequence, the molecular packing in the crystal
structure is rather different. Fig. 3 shows a possible molecular
packing of VQIVYK taking the same array as that of GNNQQNY. This
packing mode can easily interpret why the wild-type 4RMBD, andthe Q307Y/Y310A and Q307Y mutants of 4RMBD exhibit promi-
nent self-aggregation ability. In addition to the intramolecular C–
H–p interaction, a p–p stacking interaction considered to be signif-
icant for the self-assembly of ﬁbrils [7,8] is induced between
neighboring Tyr residues. Although the mechanism of tau PHF for-
mation has not yet been satisfactorily elucidated, the present work
provides important information on the key residue and structural
scaffold essential for forming a dry ‘‘steric zipper” structure in
tau amyloid ﬁbrils.References
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